CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Roivant reports top-line data from IMVT-1402 CLE trial

Data ReadoutIMVT-1402Neutral
AI Analysis

Summary

Roivant announced top-line results from the first period of a proof-of-concept clinical trial evaluating IMVT-1402 for CLE treatment.

Clinical Trial Data

Phase

Proof-of-concept

Importance:5/10
Sentiment:
0.00
Clinical TrialData ReadoutIMVT-1402CLE
Related Companies

Read the original article

Published by Clinical Trials Arena on September 24, 2026 8:32 AM

Read Original